Cardiac Biomarkers Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025

Description

The global cardiac biomarkers market is projected to grow from an estimated $20.8 billion in 2024 to $44.6 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.4% during the forecast period. This growth is driven by the increasing incidence of acute coronary syndromes (ACS), technological advancements in cardiac biomarkers, and a growing demand for point-of-care testing kits. The aging population and rising prevalence of cardiovascular diseases (CVDs) further contribute to the market expansion.

Key Insights

Troponins are the largest segment in the cardiac biomarkers market, owing to their high specificity and sensitivity in diagnosing myocardial infarction. The development of high-sensitivity troponin assays has enhanced early detection capabilities, improving patient outcomes.

The myocardial infarction category holds the largest share in the application segment, driven by the critical need for rapid and accurate diagnosis to initiate timely treatment. Cardiac biomarkers play a pivotal role in confirming myocardial infarction, guiding therapeutic decisions.

Laboratory testing remains the predominant location for cardiac biomarker analysis due to its comprehensive capabilities. However, point-of-care testing is experiencing significant growth, offering rapid results and facilitating immediate clinical decisions, especially in emergency settings.

North America holds the largest market share, attributed to advanced healthcare infrastructure and high awareness levels. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing healthcare investments and a rising burden of CVDs.

The integration of artificial intelligence (AI) and machine learning (ML) with diagnostic platforms is enhancing the identification and analysis of cardiac biomarkers. These technologies facilitate personalized therapeutic approaches and improve diagnostic accuracy.

The market is characterized by significant investments in research and development, leading to product innovations. Key players are focusing on developing novel biomarkers and enhancing the sensitivity and specificity of existing assays to maintain a competitive edge.

Product Code: 12443

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by testing location
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
- 1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview
6.2. Market Revenue, by Type (2019-2030)
6.3. Market Revenue, by Application (2019-2030)
6.4. Market Revenue, by Testing Location (2019-2030)
6.5. Market Revenue, by Region (2019-2030)

Chapter 7. North America Market

7.1. Overview
7.2. Market Revenue, by Type (2019-2030)
7.3. Market Revenue, by Application (2019-2030)
7.4. Market Revenue, by Testing Location (2019-2030)
7.5. Market Revenue, by Country (2019-2030)

Chapter 8. Europe Market

8.1. Overview
8.2. Market Revenue, by Type (2019-2030)
8.3. Market Revenue, by Application (2019-2030)
8.4. Market Revenue, by Testing Location (2019-2030)
8.5. Market Revenue, by Country (2019-2030)

Chapter 9. APAC Market

9.1. Overview
9.2. Market Revenue, by Type (2019-2030)
9.3. Market Revenue, by Application (2019-2030)
9.4. Market Revenue, by Testing Location (2019-2030)
9.5. Market Revenue, by Country (2019-2030)

Chapter 10. LATAM Market

10.1. Overview
10.2. Market Revenue, by Type (2019-2030)
10.3. Market Revenue, by Application (2019-2030)
10.4. Market Revenue, by Testing Location (2019-2030)
10.5. Market Revenue, by Country (2019-2030)

Chapter 11. MEA Market

11.1. Overview
11.2. Market Revenue, by Type (2019-2030)
11.3. Market Revenue, by Application (2019-2030)
11.4. Market Revenue, by Testing Location (2019-2030)
11.5. Market Revenue, by Country (2019-2030)

Chapter 12. U.S. Market

12.1. Overview
12.2. Market Revenue, by Type (2019-2030)
12.3. Market Revenue, by Application (2019-2030)
12.4. Market Revenue, by Testing Location (2019-2030)

Chapter 13. Canada Market

13.1. Overview
13.2. Market Revenue, by Type (2019-2030)
13.3. Market Revenue, by Application (2019-2030)
13.4. Market Revenue, by Testing Location (2019-2030)

Chapter 14. Germany Market

14.1. Overview
14.2. Market Revenue, by Type (2019-2030)
14.3. Market Revenue, by Application (2019-2030)
14.4. Market Revenue, by Testing Location (2019-2030)

Chapter 15. France Market

15.1. Overview
15.2. Market Revenue, by Type (2019-2030)
15.3. Market Revenue, by Application (2019-2030)
15.4. Market Revenue, by Testing Location (2019-2030)

Chapter 16. U.K. Market

16.1. Overview
16.2. Market Revenue, by Type (2019-2030)
16.3. Market Revenue, by Application (2019-2030)
16.4. Market Revenue, by Testing Location (2019-2030)

Chapter 17. Italy Market

17.1. Overview
17.2. Market Revenue, by Type (2019-2030)
17.3. Market Revenue, by Application (2019-2030)
17.4. Market Revenue, by Testing Location (2019-2030)

Chapter 18. Spain Market

18.1. Overview
18.2. Market Revenue, by Type (2019-2030)
18.3. Market Revenue, by Application (2019-2030)
18.4. Market Revenue, by Testing Location (2019-2030)

Chapter 19. Japan Market

19.1. Overview
19.2. Market Revenue, by Type (2019-2030)
19.3. Market Revenue, by Application (2019-2030)
19.4. Market Revenue, by Testing Location (2019-2030)

Chapter 20. China Market

20.1. Overview
20.2. Market Revenue, by Type (2019-2030)
20.3. Market Revenue, by Application (2019-2030)
20.4. Market Revenue, by Testing Location (2019-2030)

Chapter 21. India Market

21.1. Overview
21.2. Market Revenue, by Type (2019-2030)
21.3. Market Revenue, by Application (2019-2030)
21.4. Market Revenue, by Testing Location (2019-2030)

Chapter 22. Australia Market

22.1. Overview
22.2. Market Revenue, by Type (2019-2030)
22.3. Market Revenue, by Application (2019-2030)
22.4. Market Revenue, by Testing Location (2019-2030)

Chapter 23. South Korea Market

23.1. Overview
23.2. Market Revenue, by Type (2019-2030)
23.3. Market Revenue, by Application (2019-2030)
23.4. Market Revenue, by Testing Location (2019-2030)

Chapter 24. Brazil Market

24.1. Overview
24.2. Market Revenue, by Type (2019-2030)
24.3. Market Revenue, by Application (2019-2030)
24.4. Market Revenue, by Testing Location (2019-2030)

Chapter 25. Mexico Market

25.1. Overview
25.2. Market Revenue, by Type (2019-2030)
25.3. Market Revenue, by Application (2019-2030)
25.4. Market Revenue, by Testing Location (2019-2030)

Chapter 26. Saudi Arabia Market

26.1. Overview
26.2. Market Revenue, by Type (2019-2030)
26.3. Market Revenue, by Application (2019-2030)
26.4. Market Revenue, by Testing Location (2019-2030)

Chapter 27. South Africa Market

27.1. Overview
27.2. Market Revenue, by Type (2019-2030)
27.3. Market Revenue, by Application (2019-2030)
27.4. Market Revenue, by Testing Location (2019-2030)

Chapter 28. U.A.E. Market

28.1. Overview
28.2. Market Revenue, by Type (2019-2030)
28.3. Market Revenue, by Application (2019-2030)
28.4. Market Revenue, by Testing Location (2019-2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Abbott Laboratories
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
30.2. F. Hoffmann-La Roche Ltd.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
30.3. bioMerieux Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
30.4. Creative Diagnostics
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
30.5. Thermo Fisher Scientific Inc.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
30.6. Bio-Rad Laboratories Inc.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
30.7. Siemens Healthineers AG
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
30.8. Randox Laboratories Ltd.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
30.9. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
30.10. Danaher Corporation
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
30.11. Agilent Technologies Inc.
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.11.3. Key financial summary
30.12. Becton, Dickinson and Company
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.12.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations
31.2. Sources and References
31.3. Related Reports

Cardiac Biomarkers Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)